World's largest metabolomic study completed, paving way for predictive medicine
EurekAlert!4 days
The Theranos scandal proves that claims about revolutionary blood testing using tiny samples are dangerous pipe dreams. Physical limitations make detecting multiple biomarkers from drops of blood scientifically impossible since most disease markers exist in extremely low concentrations. Relying on small sample diagnostics leads to misdiagnosis and delayed treatment.
Pinprick blood tests are revolutionizing healthcare by predicting diseases up to 10 years before symptoms appear. Scientists can now measure thousands of proteins and molecules from a single drop, creating accurate risk signatures for cancer, heart disease and dementia. This breakthrough shifts medicine toward prevention rather than reactive treatment.
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.18.0